does tirzepatide affect sleep The FDA approved Zepbound in December 2024 for the treatment of moderate-to-severe obstructive apnea in patients with obesity after research showed that the medication improved outcomes in these patients. Sleep apnea What clinicians should know about

We are investigating whether RxSugar misrepresented its dietary supplements by marketing them as natural GLP-1 boosters and claiming they can reduce users appetites and satisfy cravings

Pt9 Blood Sugars Role Pt10 Genes & Lifestyle In the ongoing journey to explore how food impacts mental health, its not just the usual suspects like gluten and dairy that can play a significant role

Naltrexone-bupropion (Contrave) targets the brains reward centers to reduce cravingsparticularly useful for patients whose weight gain is driven by emotional or compulsive eating patterns

En el estudio STEP-1 (Semaglutide Treatment Effect in People with obesity), publicado en The New England Journal of Medicine, participantes con obesidad pero sin diabetes lograron una prdida de peso promedio de 14.9% del peso corporal inicial con semaglutide 2.4 mg semanal

Objective identification and prioritisation of people at highest clinical in resource stretched healthcare systems can be challenging

My Expert Opinion Ozempic does the heavy lifting for you, enabling you to make the best choices most of the time